Clinical trial
A Phase I/IIa Study of ODX (OsteoDex) in Multiple Myeloma
NCT06616389 is registered in ClinicalTrials.gov with DexTech Medical AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/IIa Study of ODX (OsteoDex) in Multiple Myeloma
- Lead sponsor
- DexTech Medical AB
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- November 29, 2023
- Completion date
- January 30, 2026
- Enrollment
- 12 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.